Septolete Total tab for the races. 3mg + 1mg 16 pcs lemon / honey

Description

Composition
Active substance:
Benzydamine hydrochloride, 3,000 mg of cetylpyridinium chloride monohydrate 1.050 mg, equivalent to 1.000 mg of cetylpyridinium chloride
Excipients:
Isomalt (Type M) (E953), citric acid (E330), sucralose (E955), honey flavoring, lemon flavoring, levomenthol, dye curcumin (E100) 1), peppermint leaf oil.
1) A dye curcumin (E100): curcumin (E100), maltodextrin, acacia gum (E414),
emulsifier (E472s), citric acid (E330), potassium sorbate (E202), sodium benzoate (E211)
purified water.
Description:
Round tablets with bevelled edges with a rough surface from light yellow to yellow. Allowed white coating, uneven coloring, the presence of air bubbles in the candy mass and a slight unevenness of the edges
Product form:
Lozenges [elder and lemon] 3 mg + 1 mg.
To 8 tablets in the blister of the composite material of PVC / PE / PVDC aluminum -folgi.
2 is placed in a blister pack carton along with instructions for use.
Contraindications
Hypersensitivity to the active ingredients or to any auxiliary ingredients.
Children under 6 years
Carefully
Increased sensitivity to aspirin or other nonsteroidal anti-inflammatory drugs, bronchial asthma (r. H. In history).
Dosage
3 mg + 1 mg
Indications
Symptomatic therapy of oral pain and inflammatory diseases of upper respiratory tract (different etiology), including tonsillitis, pharyngitis, in combined therapy.
Interaction with other drugs
It has not been studied. simultaneous application should be avoided with other drugs from the group of antiseptics.
Overdose
Symptoms: The toxic manifestations benzydamine overdose include:
agitation, convulsions, sweating, ataxia, vomiting and chills. Signs and symptoms of intoxication by ingestion of significant quantities of cetylpyridinium chloride: nausea, vomiting, edema, cyanosis, asphyxiation followed by paralysis of the respiratory muscles, central nervous system depression, hypotension, and coma.
A lethal dose for humans is about 1-3 g
Treatment: due to the absence of a specific antidote, treatment of acute intoxication benzydamine symptomatic. Treatment of overdoses cetylpyridinium chloride also symptomatic. In case of overdose, seek medical attention.
pharmachologic effect
Pharmacological group:
nonsteroidal anti-inflammatory drug + antiseptic
Pharmacodynamics:
Benzydamine – a non-steroidal anti-inflammatory agent, anti-inflammatory, analgesic and local anesthetic action.
Cetylpyridinium chloride – preservative from the group consisting of quaternary ammonium compounds having antimicrobial, antifungal, virucidal action.
Pharmacokinetics:
Suction
Of the two active substances – cetyl pyridinium chloride and benzydamine – mucosally absorbed only benzydamine. Therefore, cetylpyridinium chloride does not come into engagement with benzydamine pharmacokinetic at the system level.
Benzydamine absorption through the mucous membranes of the oral cavity and pharynx has been shown, by identifying active substance in the serum, the amount of which, however, it was not sufficient to provide systemic action. Suction benzydamine higher with dosage forms that dissolve in the mouth compared to dosage forms for local application (e.g.,
spray for oral cavity).
Distribution
The volume of distribution of all forms of the same drug.
breeding
Withdrawal takes place in the kidneys to a greater extent, in the form of inactive metabolites. The half-life and total body clearance is similar for all dosage forms.
Pregnancy and breast-feeding
Pregnancy
Before using the product Septolete® total is, if you are pregnant, or suspect
that you might be pregnant, or planning to become pregnant, you must consult your doctor.
Breastfeeding
During the period of breast-feeding before using the drug Septolete® total it is necessary to consult with your doctor.
Conditions of supply of pharmacies
Without a prescription.
side effects
Classification of the incidence of side effects, recommended by the World Health Organization (WHO):
often> 1/10
often by> 1/100 to 1/1000 to 1/10000 to
Violations by the immune system:
rare: hypersensitivity reactions;
frequency is unknown: anaphylactic reactions.
Disorders of the nervous system:
frequency is unknown: numbness of the oral mucosa.
Violations of the respiratory system, thorax and mediastinum:
rare: bronchospasm.
Disorders of the gastrointestinal tract: Very rare: irritation of the oral mucosa, burning sensation in the mouth.
Violations of the skin and subcutaneous tissue disorders:
rare: rash, photosensitivity;
frequency is unknown: angioedema, pruritus
special instructions
Total Septolete® drug should not be used longer than 7 days. If no visible signs improvement should consult a physician.
In applying the drug Septolete® Totals may develop hypersensitivity reactions. In this case, it is recommended to discontinue treatment and consult a doctor for the appointment of appropriate therapy.
If there is ulceration of the mucous membrane of the oropharynx, the patient should seek medical advice if symptoms persist for more than three days. Use of the drug Septolete® total is not recommended in patients with hypersensitivity to aspirin or other nonsteroidal antiinflammatory drugs.
Preparation Septolete ® total is not to be used in conjunction with anionic compounds (e.g., present in toothpaste). For optimal effect should not use the drug Septolete®
the total is immediately before or after brushing.
Simultaneous treatment with milk may reduce the antimicrobial action of cetylpyridinium chloride, the total is therefore Septolete® preparation should not be used simultaneously with milk.
The effect on the ability to operate vehicles, machinery
Total Septolete® drug has no effect on the ability to drive vehicles and operate machinery.
Storage conditions
At temperatures above 25 ° C, in the original package.
Keep out of the reach of children.
Dosing and Administration
The tablets should dissolve slowly in the mouth every 3-6 hours.
Adults, elderly patients and children over 12 years
The recommended dose is 3-4 tablets per day.
Children 6 to 12 years
The recommended dosage is 3 tablets per day.
Do not exceed this dose.
Total Septolete® drug should not be used concomitantly with other drugs from the group of antiseptics.
Total Septolete® drug should not be used for more than 7 days
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist